Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005840
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT00977574
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 349
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Not applicableUnknownNCT01150682
What this trial is testing

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 865
Not applicableStudy completedNCT03339765
What this trial is testing

Self-Advocacy Serious Game in Advanced Cancer

Who this might be right for
Ovarian Cancer Stage IIIOvarian Cancer Stage IVBreast Cancer Stage IV+10 more
University of Pittsburgh 78
Testing effectiveness (Phase 2)Study completedNCT00004251
What this trial is testing

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
NCIC Clinical Trials Group 33
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01397877
What this trial is testing

GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
ARCAGY/ GINECO GROUP 24
Testing effectiveness (Phase 2)Study completedNCT00003946
What this trial is testing

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Not applicableStudy completedNCT01344837
What this trial is testing

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Who this might be right for
Endometrial Serous AdenocarcinomaStage I Uterine Corpus CancerStage II Uterine Corpus Cancer+2 more
Gynecologic Oncology Group 360
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT03276013
What this trial is testing

Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Vall d'Hebron Institute of Oncology 48
Not applicableLooking for participantsNCT06855706
What this trial is testing

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Who this might be right for
Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+10 more
Roswell Park Cancer Institute 120
Testing effectiveness (Phase 2)Study completedNCT04080284
What this trial is testing

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Who this might be right for
Endometrial CancerPapillary Serous Endometrial CarcinomaUterine Serous Carcinoma+2 more
Northwell Health 22
Not applicableLooking for participantsNCT04997096
What this trial is testing

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

Who this might be right for
Ovarian CancerOvarian CarcinomaOvarian Cancer Stage IV+4 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Testing effectiveness (Phase 2)Study completedNCT00003939
What this trial is testing

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more
European Organisation for Research and Treatment of Cancer - EORTC 132
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Next Page